Active Pharmaceutical Ingredients Market Analysis,

Size, Growth, Share, Trend, Forecast 2023 – 2030

Active Pharmaceutical Ingredients Market Growth & Trends

The global active pharmaceutical ingredients market size is expected to reach USD 352.98 billion by 2030, expanding at a compound annual growth rate (CAGR) of 6.0% during the forecast period, according to a new report by Grand View Research, Inc. The market is driven by the growth of the biopharmaceutical sector, advancements in active pharmaceutical Ingredients (API) manufacturing, and an increase in the geriatric population.

The growth of the captive API segment is propelled by companies investing in solving challenges and developing new chemical ways for the production of APIs in-house. This aids in reducing costs and the risk of contamination. Artificial intelligence and protein synthesis are expected to facilitate faster development with greater control over the process.

The rising prevalence of chronic and lifestyle-based conditions, such as cardiovascular diseases, is accelerating the demand for API. For instance, as per U.S. Pharmacist in 2020, 47% of adults have at least one risk factor that supports cardiovascular disease development. Cardiovascular diseases are one of the global, critical public health burdens driving extensive R&D for APIs in the field.

Browse full report with Table of Content (PDF with All Related Graph and Chart)

@: https://www.grandviewresearch.com/industry-analysis/active-pharmaceutical-ingredients-market

To address unmet medical needs, companies are collaborating to develop novel treatments. This allows firms to use their resources to aid in the development of products and enhance the supply chain. In November 2021, Merck & Co Inc. announced that it has acquired Acceleron Pharma, this acquisition would help Merck & Co to expand their cardiovascular portfolio and pipeline.

Active Pharmaceutical Ingredients Market Report Highlights

 Innovative APIs held the largest share of 47.07% in 2022, owing to increasing research and development activities for novel drug development and positive government initiatives

 The cardiovascular disease segment held the largest revenue share of 21.54% in 2022, attributed to the rising prevalence of target disease globally

 The synthetic API segment dominated the market with the largest revenue share of 72.6% in 2021, owing to the higher availability of raw materials and easier protocols for the synthesis of these molecules

 North America accounted for the largest revenue share of 38.80% in 2021 and is expected to maintain its lead over the forecast period. This is attributed to the rising epidemiology of cancer, along with other lifestyle-induced diseases, thus encouraging the R&D activities, thereby boosting the market growth

Active Pharmaceutical Ingredients Market Segmentation

GrandViewResearchhassegmentedtheglobalactivepharmaceuticalIngredients marketbasedonthetypeofsynthesis,typeofmanufacturer,type,application,typeof drugandregion:

Active Pharmaceutical Ingredients Type of Synthesis Outlook (Revenue, USD Billion, 2018 - 2030)

 Biotech o BiotechAPIsMarket,ByType(Revenue,USDBillion,20182030) o GenericAPIs o InnovativeAPIs o BiotechAPIsMarket,ByType(Revenue,USDBillion,20182030) o MonoclonalAntibodies o Hormones o Cytokines

 Synthetic o RecombinantProteins o TherapeuticEnzymes o Vaccines o BloodFactors o SyntheticAPIsMarket,ByType(Revenue,USDBillion,2018 -2030) o GenericAPIs o InnovativeAPIs

Active Pharmaceutical Ingredients Type of Manufacturer Outlook (Revenue, USD Billion, 2018 - 2030)

 CaptiveAPIs

 MerchantAPIs o MerchantAPIsMarket,ByType(Revenue,USDBillion,2018 -2030) o GenericAPIs o InnovativeAPIs o MerchantAPIsMarket,ByType(Revenue,USDBillion,2018 -2030) o Biotech o Synthetic

Active Pharmaceutical Ingredients Type Outlook (Revenue, USD Billion, 20182030)

 GenericAPIs

 InnovativeAPIs

For Requesting a Sample Copy of This Report, Please Visit @ https://www.grandviewresearch.com/industry-analysis/active-pharmaceutical-ingredientsmarket/request/rs1

Active Pharmaceutical Ingredients Type of Drug (Revenue, USD Billion, 20182030)

 PrescriptionDrugs

 Over-the-counterDrugs

Active Pharmaceutical Ingredients Application Outlook (Revenue, USD Billion, 2018 - 2030)

 CardiovascularDiseases

 Oncology

 CNSandNeurology

 Orthopedic

 Endocrinology

 Pulmonology

 Gastroenterology

 Nephrology

 Ophthalmology

 Others

Active Pharmaceutical Ingredients Regional Outlook (Revenue, USD Billion, 20182030)

 NorthAmerica o U.S. o Canada

 Europe o U.K. o Germany o France o Italy o Spain o Russia o Hungary

 AsiaPacific o Japan o China o India o SouthKorea o Australia

 LatinAmerica o Brazil o Mexico o Argentina

 MiddleEast&Africa o SouthAfrica o UAE o SaudiArabia o Egypt o Israel

List of Key Players in the Active Pharmaceutical Ingredients Market

 Merck&Co.,Inc.

 AbbVie,Inc.

 Bristol-MyersSquibbCompany

 BoehringerIngelheimInternationalGmbH

 Cipla,Inc.

 TevaPharmaceuticalIndustriesLtd.

 AlbemarleCorporation

 ViatrisInc.

 AurobindoPharma

 SunPharmaceuticalIndustriesLtd.

 Dr.Reddy’sLaboratoriesLtd.

For Requesting a Free Consultation https://www.grandviewresearch.com/request-freeconsultation/658/rfc

Why Purchase this Report?

 A strong research methodology was followed to collect data for the report. The data collected in this way are subjected to several quality checks to provide the best quality.

 The report provides a holistic view of the Active Pharmaceutical Ingredients Market.

 The latest product launches, along with technological changes and developments, are included in the report.